CDC says J&J Covid vaccine is OK for people who have allergic reaction to Pfizer or Moderna's

  • 📰 CNBC
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 72%

United States Headlines News

United States Latest News,United States Headlines

There were 47 reports of severe allergic reactions in those who received Pfizer's vaccine and 19 cases in those who received Moderna's as of Jan. 18, CDC said.

's shots for those who have an allergic reaction to the first round of either company's vaccine, a scientist for the Centers for Disease Control and Prevention said Monday.

"In exceptional situations where the first dose of an mRNA Covid-19 vaccine was received, but the patient is unable to complete the series with either the same or a different mRNA Covid-19 vaccine, for example due to a contraindication, a single dose of Janssen's Covid-19 vaccine may be administered at a minimum interval of 28 days from the mRNA COVID-19 vaccine dose," she said Monday at an emergency meeting of the CDC's Advisory Committee on Immunization Practices.

The CDC's MacNeil noted that the vaccines "are not interchangeable" and that the safety and efficacy of taking one shot of the Pfizer or Moderna vaccine and one of the J&J vaccine has not been tested. She added that people who get J&J's should do so "under the supervision of a health-care provider."

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Recently my friend's baby was diagnosed with acute lymphocytic leukemia & needs a stem cell transplant. Jason & his wife are first-time parents caring for a sick baby & could use some help. If you are in a place to donate or share, it would be appreciated.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.